The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Integrative Clinical Genomics of Advanced Prostate Cancer
Robinson, D., Van Allen, E. M., Wu, Y.-M., Schultz, N., Lonigro, R. J., Mosquera, J.-M., Montgomery, B., Taplin, M.-E., Pritchard, C. C., Attard, G., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.001 · Cited by 3,645
Self-citationEpstein, J. I., Egevad, L., Amin, M. B., Delahunt, B., Srigley, J. R., & Humphrey, P. A. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000530 · Cited by 3,236
Self-citationThe Molecular Taxonomy of Primary Prostate Cancer
Abeshouse, A., Ahn, J., Akbani, R., Ally, A., Amin, S., Andry, C. D., Annala, M., Aprikian, A., Armenia, J., Arora, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.025 · Cited by 3,110
Self-citationComprehensive molecular characterization of urothelial bladder carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,990
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Powles, T., Eder, J. P., Fine, G. D., Braiteh, F. S., Loriot, Y., Cruz, C., Bellmunt, J., Burris, H. A., Petrylak, D. P., Teng, S.-L., et al. (2014) · Nature · doi:10.1038/nature13904 · Cited by 2,381
Pathology and genetics of tumours of the urinary system and male genital organs
Eble, J. N. (2004) · International Agency for Research on Cancer eBooks · Cited by 1,596
Epstein, J. I., Amin, M. B., Reuter, V. R., & Mostofi, F. K. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199812000-00001 · Cited by 1,578
Self-citationA Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
Epstein, J. I., Zelefsky, M. J., Sjoberg, D. D., Nelson, J. B., Egevad, L., Magi-Galluzzi, C., Vickers, A. J., Parwani, A. V., Reuter, V. E., Fine, S. W., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.06.046 · Cited by 1,374
Self-citationWHO Classification of of Tumours of the Urinary System and Male Genital Organs
Ulbright, T. M., Amin, M. B., Balzer, B. W. R., Berney, D. M., Epstein, J., Guo, C. C., Idrees, M. T., Looijenga, L. H. J., Paner, G. P., Meyts, E. R., et al. (2016) · Cited by 915
Self-citationIntrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Damrauer, J. S., Hoadley, K. A., Chism, D. D., Fan, C., Tiganelli, C. J., Wobker, S. E., Yeh, J. J., Milowsky, M. I., Iyer, G., Parker, J. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318376111 · Cited by 877
Prognostic G leason grade grouping: data based on the modified G leason scoring system
Pierorazio, P. M., Walsh, P. C., Partin, A. W., & Epstein, J. I. (2013) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11611.x · Cited by 751
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.907 · Cited by 747
Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs
Ball, R. Y. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02096.x · Cited by 583
Sanchez-Carbayo, M., Socci, N. D., Lozano, J., Saint, F., & Cordon-Cardo, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2375 · Cited by 550
Guo, G., Sun, X., Chen, C., Wu, S., Huang, P., Li, Z., Dean, M., Huang, Y., Jia, W., Zhou, Q., et al. (2013) · Nature Genetics · doi:10.1038/ng.2798 · Cited by 482
Inman, B. A., Sebo, T. J., Frigola, X., Dong, H., Bergstralh, E. J., Frank, I., Fradet, Y., Lacombe, L., & Kwon, E. D. (2007) · Cancer · doi:10.1002/cncr.22588 · Cited by 438
CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIES
DALBAGNI, G., GENEGA, E., HASHIBE, M., ZHANG, Z.-F., RUSSO, P., HERR, H., & REUTER, V. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66440-3 · Cited by 434
Self-citationSlade, I., Bacchelli, C., Davies, H., Murray, A., Abbaszadeh, F., Hanks, S., Barfoot, R., Burke, A., Chisholm, J., Hewitt, M., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.083790 · Cited by 371
van Rhijn, B. W. G., Vis, A. N., van der Kwast, T. H., Kirkels, W. J., Radvanyi, F., Ooms, E. C. M., Chopin, D. K., Boevé, E. R., Jöbsis, A. C., & Zwarthoff, E. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.073 · Cited by 322
Amin, M. B., Epstein, J. I., Ulbright, T. M., Humphrey, P. A., Egevad, L., Montironi, R., Grignon, D., Trpkov, K., Lopez-Beltran, A., Zhou, M., et al. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000254 · Cited by 314
Self-citationLindgren, D., Frigyesi, A., Gudjonsson, S., Sjödahl, G., Hallden, C., Chebil, G., Veerla, S., Ryden, T., Månsson, W., Liedberg, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4213 · Cited by 310
Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer
Iyer, G., Al-Ahmadie, H., Schultz, N., Hanrahan, A. J., Ostrovnaya, I., Balar, A. V., Kim, P. H., Lin, O., Weinhold, N., Sander, C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5740 · Cited by 309
Self-citationIntrinsic basal and luminal subtypes of muscle-invasive bladder cancer
Choi, W., Czerniak, B., Ochoa, A., Su, X., Siefker-Radtke, A., Dinney, C., & McConkey, D. J. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.129 · Cited by 302
Allory, Y., Beukers, W., Sagrera, A., Flández, M., Marqués, M., Márquez, M., van der Keur, K. A., Dyrskjot, L., Lurkin, I., Vermeij, M., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.08.052 · Cited by 284
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Hay, D. A., Fedorov, O., Martin, S., Singleton, D. C., Tallant, C., Wells, C., Picaud, S., Philpott, M., Monteiro, O. P., Rogers, C. M., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412434f · Cited by 277
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
Sauter, G., Steurer, S., Clauditz, T. S., Krech, T., Wittmer, C., Lutz, F., Lennartz, M., Janssen, T., Hakimi, N., Simon, R., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.10.029 · Cited by 275
Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy
Balbás-Martínez, C., Sagrera, A., Carrillo-de-Santa-Pau, E., Earl, J., Márquez, M., Vazquez, M., Lapi, E., Castro-Giner, F., Beltran, S., Bayés, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2799 · Cited by 273
Kamat, A. M., Hegarty, P. K., Gee, J. R., Clark, P. E., Svatek, R. S., Hegarty, N., Shariat, S. F., Xylinas, E., Schmitz-Dräger, B. J., Lotan, Y., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.09.057 · Cited by 263
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
Knowles, M. A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi310 · Cited by 248
The Mutational Landscape of Prostate Cancer
Barbieri, C. E., Bangma, C. H., Bjartell, A., Catto, J. W. F., Culig, Z., Grönberg, H., Luo, J., Visakorpi, T., & Rubin, M. A. (2013) · European Urology · doi:10.1016/j.eururo.2013.05.029 · Cited by 239
The Role of Telomeres in Stem Cells and Cancer
Günes, C., & Rudolph, K. L. (2013) · Cell · doi:10.1016/j.cell.2013.01.010 · Cited by 232
Hartmann, A., Moser, K., Kriegmair, M., Hofstetter, A., Hofstaedter, F., & Knuechel, R. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65318-7 · Cited by 189
Evans, A. J., Humphrey, P. A., Belani, J., van der Kwast, T. H., & Srigley, J. R. (2006) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200606000-00003 · Cited by 179
Self-citationA comprehensive systematic review of testicular germ cell tumor surveillance
Groll, R. J., Warde, P., & Jewett, M. A. S. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.04.014 · Cited by 173
Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer
Nordentoft, I., Lamy, P., Birkenkamp‐Demtröder, K., Shumansky, K., Vang, S., Hornshøj, H., Juul, M., Villesen, P., Hedegaard, J., Roth, A. J. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.038 · Cited by 159
Ross, J. S., Wang, K., Gay, L. M., Al-Rohil, R. N., Nazeer, T., Sheehan, C. E., Jennings, T. A., Otto, G. A., Donahue, A. L., He, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1992 · Cited by 158
Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder
Kim, P. H., Cha, E. K., Sfakianos, J. P., Iyer, G., Zabor, E. C., Scott, S. N., Ostrovnaya, I., Ramirez, R. J., Sun, A. J., Shah, R. H., et al. (2014) · European Urology · doi:10.1016/j.eururo.2014.06.050 · Cited by 153
Self-citationPredictive Value of Cell Cycle Biomarkers in Nonmuscle Invasive Bladder Transitional Cell Carcinoma
Shariat, S. F., Ashfaq, R., Sagalowsky, A. I., & Lotan, Y. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.09.038 · Cited by 143
Obermann, E. C., Junker, K., Stoehr, R., Dietmaier, W., Zaak, D., Schubert, J., Hofstaedter, F., Knuechel, R., & Hartmann, A. (2002) · The Journal of Pathology · doi:10.1002/path.1259 · Cited by 129
Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
Netto, G. J. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.193 · Cited by 127
Amin, M. B., Smith, S. C., Reuter, V. E., Epstein, J. I., Grignon, D. J., Hansel, D. E., Lin, O., McKenney, J. K., Montironi, R., Paner, G. P., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.158 · Cited by 120
Self-citation[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains
Fedorov, O., Lingard, H., Wells, C. D., Monteiro, O., Picaud, S., Keates, T., Yapp, C., Philpott, M., Martin, S. J., Felletár, I., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401568s · Cited by 106
Lin, O., Cardillo, M., Dalbagni, G. M., Linkov, I., Hutchinson, B., & Reuter, V. E. (2003) · Modern Pathology · doi:10.1097/01.mp.0000094091.04541.fc · Cited by 105
Self-citationThe FGFR3 Mutation is Related to Favorable pT1 Bladder Cancer
van Rhijn, B. W. G., van der Kwast, T., Liu, L., Fleshner, N. E., Boström, P. J., Vis, A. N., Alkhateeb, S. S., Bangma, C. H., Jewett, M. A. S., Zwarthoff, E. C., et al. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.09.008 · Cited by 101
Primary adenocarcinoma of the urinary bladder:
EL‐Mekresh, Elbaz, Abol‐Enein, & Ghoneim, G. (1998) · British Journal of Urology · doi:10.1046/j.1464-410x.1998.00718.x · Cited by 100
Molecular evolution of multiple recurrent cancers of the bladder
van Tilborg, A. A. G. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.2973 · Cited by 91
Schneider, S. A., Sukov, W. R., Frank, I., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.201 · Cited by 84
Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy
Liang Cheng, C., Davidson, D. D., Lin, H., & Koch, M. O. (2007) · Cancer · doi:10.1002/cncr.23004 · Cited by 66
Blochin, E., Park, K. J., Tickoo, S. K., Reuter, V. E., & Al‐Ahmadie, H. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.112 · Cited by 54
Self-citationMagers, M. J., Kunju, L. P., & Wu, A. J. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0206-ra · Cited by 35
Genomic rearrangements in prostate cancer
Barbieri, C. E., & Rubin, M. A. (2014) · Current Opinion in Urology · doi:10.1097/mou.0000000000000129 · Cited by 30
Fahmy, M. A., Mansure, J. J., Brimo, F., Yafi, F. A., Segal, R., Althunayan, A. M., Hicks, J. L., Meeker, A. K., Netto, G. J., & Kassouf, W. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.11.026 · Cited by 28
González-Roibón, N., Chaux, A., Al-Hussain, T. O., Osunkoya, A. O., Bezerra, S. M., Hicks, J. L., Epstein, J. I., & Netto, G. J. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.07.009 · Cited by 18
Primary vesical clear cell adenocarcinoma arising in endometriosis: a rare case of mullerian origin.
Lah, K., Desai, D. J., Hadway, P., Perry‐Keene, J., & Coughlin, G. (2013) · PubMed · Cited by 14
Gene profiling suggests a common evolution of bladder cancer subtypes
Hansel, D. E., Zhang, Z., Petillo, D., & Teh, B. T. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-42 · Cited by 12
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Lee, S. H., Hu, W., Matulay, J. T., Silva, M. V., Owczarek, T. B., Kim, K., Chua, C. W., Barlow, L. J., Kandoth, C., Williams, A. B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.017 · Cited by 873
van Leenders, G. J. L. H., van der Kwast, T. H., Grignon, D. J., Evans, A. J., Kristiansen, G., Kweldam, C. F., Litjens, G., McKenney, J. K., Melamed, J., Mottet, N., et al. (2020) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001497 · Cited by 713
Panebianco, V., Narumi, Y., Altun, E., Bochner, B. H., Efstathiou, J. A., Hafeez, S., Huddart, R., Kennish, S., Lerner, S., Montironi, R., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.04.029 · Cited by 658
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Powles, T., Bellmunt, J., Comperat, E., De Santis, M., Huddart, R., Loriot, Y., Necchi, A., Valderrama, B. P., Ravaud, A., Shariat, S. F., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2021.11.012 · Cited by 555
Metadata
- Authors
- Humphrey, P. A., Moch, H., Cubilla, A. L., Ulbright, T. M., & Reuter, V. E.
- Venue
- European Urology
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 70
- Issue
- 1
- Pages
- 106-119
- ISSN
- 0302-2838 (ISSN-L)
- OpenAlex
- W2301685087
- Cited by
- 1,916
- References
- 57
- FWCI
- 119.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.